ABSTRACT
INTRODUCTION
Fetal growth restriction and being small-for-gestational age (SGA) are major causes of adverse perinatal outcome [1] [2] [3] . Ultrasound is the method commonly used in practice for SGA screening; however, screening accuracy is variable between studies and is relatively poor [4] [5] [6] [7] [8] [9] [10] [11] [12] . Biometric measurements are reported on the basis of fetal growth curves. While, historically, Hadlock's curve 10, 11 is the most common standard used to evaluate percentiles of fetal measurements, its sensitivity and specificity are low 12 . Furthermore, it is unclear which method is best for SGA prediction: using a single parameter, such as abdominal circumference (AC), or using estimated fetal weight (EFW) based on different formulae incorporating various parameters.
Many authors have tried to improve sensitivity by developing new fetal growth curves [6] [7] [8] [9] . The charts proposed by the INTERGROWTH-21 st Project 6 or by Salomon et al. 9 could fit more precisely fetal ultrasound measurements. Moreover, Gardosi et al. 7, 8 proposed customization of growth charts according to maternal characteristics (height, weight, parity, ethnicity) and fetal gender. Another approach is to study fetal growth velocity between two ultrasound measurements 13 . A recent study by Sovio et al. 14 suggested that universal screening of nulliparous women with third-trimester fetal biometry and assessment of growth velocity could identify a subset of SGA fetuses at increased risk of neonatal morbidity. To date, however, there is no evidence that any particular method performs best. The impact of gestational age at screening also needs to be considered; several studies have examined this, with most concluding that late third-trimester ultrasound performs better than does early ultrasound at predicting SGA [15] [16] [17] [18] [19] [20] .
The aim of this study was to compare different ultrasound SGA screening models and to evaluate the impact of the ultrasound-delivery interval on the prediction of SGA.
METHODS
This study was based on the prospective multicenter IRNPQEO (Integrated Research Network in Perinatology of Quebec and Eastern Ontario) 3D cohort study 21 conducted in nine hospitals in the province of Quebec, Canada. Between May 2010 and August 2012, pregnant women and their partners were recruited in the first trimester of pregnancy and followed, along with their children, until 2 years after birth, with 2366 women ultimately participating. A large number of demographic, clinical and biological variables were collected on mother-father-child trios. The overall goal of the cohort was to study the effects of different factors on the course of pregnancy and on maternal, fetal and neonatal health and child development. Senior data managers reviewed all data for consistency and completeness prior to data entry. In cases of diagnostic or clinical doubt regarding data, all recruiters had access to a local expert to discuss the information following international recommendations. SGA was defined as birth weight < 10 th percentile according to Kramer birth-weight curves 22 . Gestational age was determined by first-trimester measurement of crown-rump length 23 . All patients gave their signed consent to participate and the ethics committee of Sainte-Justine Hospital, Montreal, Quebec, approved the study.
Baseline characteristics were collected at the first-trimester visit, including: maternal age, weight, height, body mass index (BMI), ethnicity (white or non-white), parity, use of an assisted reproductive technique (yes or no), smoking status (current smoker or non-smoker), history of chronic hypertension, previous gestational hypertension, previous or current pre-eclampsia, eclampsia or diabetes mellitus. At the same time, paternal characteristics were collected, including: paternal age, weight, height, BMI and smoking status. Women with fetal malformation, chromosomal anomaly or multiple pregnancy were excluded. Data on perinatal outcome were also collected, such as: Cesarean section for fetal distress (yes or no), Apgar score at 5 min, admission to neonatal intensive care unit (NICU, yes or no), stillbirth (yes or no) and neonatal death (defined as neonatal death during the 28 days after birth, yes or no).
For the purposes of our present study, comparing ultrasound-screening methods in the prediction of SGA, we included from the IRNPQEO study 21 cohort all patients who had a third-trimester ultrasound examination performed between 28 and 41 weeks of gestation. There is no policy regarding systematic third-trimester ultrasound screening in Canada, but it was strongly encouraged for the purpose of this study. A report was completed for each patient, including fetal measurements of biparietal diameter, AC and femur length. Experienced sonographers and physicians performed standardized measurements following standard guidelines 24 for biometry, but no specific recommendation was given to sonographers in the study protocol. We compared the following ultrasound screening methods: single measurement of AC according to Hadlock curves (Hadlock AC) 11 Table 1 . We standardized the fetal ultrasound measurements using the Z-score (observed measure -mean value)/SD. The Gardosi model 7, 8 estimates an optimal weight for 280 days of gestation and gives an optimal weight percentage for each gestational age. To calculate it, coefficients were needed for maternal height, maternal weight, parity, ethnicity and fetal gender. These coefficients were based on the United States population 8 because no coefficient was available for the Canadian population. In order to obtain a standardized EFW from the Gardosi model, we used our Z-score formulae with Hadlock EFW 10 as fetal weight reference. Optimal weight and SD were calculated for each third-trimester ultrasound screening. To study the impact of ultrasound-delivery interval we defined three interval groups: ≤ 4 weeks, ≤ 6 weeks and ≤ 10 weeks.
Statistical analysis
We compared the different ultrasound screening methods as predictors of SGA and studied the impact of the ultrasound-delivery interval on SGA diagnostic sensitivity and false-positive rate (FPR). We performed Student's t-tests for continuous variables and chi-square Fetal growth velocity of AC between second and third trimesters (AC3-AC2)/(AG3-AG2), where AC2 is second-trimester AC, AC3 is third-trimester AC, AG3 is GA at third-trimester ultrasound and AG2 is GA at second-trimester ultrasound Z-score (Ultrasound measurement -mean value for GA)/SD for GA *'ao' are add-ons for maternal height (ht), maternal weight at booking (wt), ethnic origin (eth), parity (par) and gender of fetus/neonate (sex). AC, abdominal circumference; EFW, estimated fetal weight; FL, femur length; GA, gestational age; TOW, term optimal weight.
tests for categorical variables. Logistic regressions were performed to evaluate each diagnostic method and receiver-operating characteristics (ROC) curves were produced. To compare ROC curves, we used the DeLong method 25 . P-values < 0.05 were considered statistically significant. All statistical analyses were performed using SPSS version 22.0 (SPSS inc., Chicago, IL, USA) and Medcalc (Medcalc Software, Mariakerke, Belgium).
RESULTS
In total, 2366 women were recruited, of whom 1805 had complete outcome data and a third-trimester ultrasound examination performed (median gestational age, 32 (interquartile range, 31-33) weeks), including 158 (8.8%) who delivered a SGA neonate. The ultrasound-delivery interval was 4 weeks or less in 17.2% (n = 311) of cases, of which 24 (7.7%) delivered a SGA neonate, 6 weeks or less in 48.1% (n = 869), of which 66 (7.6%) delivered a SGA neonate, and 10 weeks or less in 97.3% (n = 1757), of which 148 (8.4%) delivered a SGA neonate. Maternal and paternal characteristics are shown in Table 2 . There were statistically significant differences (P < 0.05) between pregnancies delivering and those not delivering a SGA neonate: maternal height, weight and BMI, nulliparity, pre-eclampsia, current maternal smoking and birth weight. When considered as a categorical variable, maternal BMI < 19 kg/m 2 was not statistically different between the groups (P = 0.252) but maternal BMI > 30 kg/m 2 was (P = 0.002; odds ratio, 0.36 (95% CI, 0.19-0.70)). Paternal weight and BMI were also statistically significantly different between SGA and non-SGA groups. With respect to perinatal outcome, Cesarean delivery for fetal distress and admission to NICU were significantly more frequent among SGA neonates. 
Comparison of methods
Results from logistic regression analyses comparing performance of each SGA screening method are presented in Table 3 and ROC curves are presented in Figure 1 . Areas under the ROC curves (AUCs) were 0.772 for Salomon AC, 0.768 for Hadlock EFW, 0.766 for Hadlock AC, 0.765 for Intergrowth AC, 0.708 for Gardosi EFW and 0.674 for FGVAC (all P < 0.0001). Sensitivities and FPRs are presented in Table 3 . Each ROC curve was compared with the others by the method of DeLong et al. 25 (Table 4) . For a FPR of 10%, the Salomon AC, Intergrowth AC and Hadlock AC were the best predictors. Between these prediction models, ROC curve comparisons showed statistical differences for Salomon AC vs Intergrowth AC (P = 0.0044) and Salomon AC vs Hadlock AC (P = 0.0017), but no statistical difference between Intergrowth AC and Hadlock AC (P = 0.2213).
Results and AUCs for the comparison of each method at different ultrasound-delivery intervals are presented in Table 5 . All AUC P-values were < 0.0001. A shorter ultrasound-delivery interval provided better prediction than did a longer interval.
DISCUSSION
Our results confirm that third-trimester ultrasound measurements are a poor predictor of SGA and that a shorter ultrasound-delivery interval provides better prediction. Sensitivities were 60% or lower for a 10% FPR with an ultrasound-delivery interval ≤ 4 weeks, and 42% or lower for an interval ≤ 10 weeks.
AC alone appeared to be the best predictor of SGA. Sensitivities were very similar using the Hadlock 11 , Salomon 9 or INTERGROWTH-21 st6 formulae, and these models performed significantly better than the Gardosi 7, 8 and FGVAC models. Using the single measure of AC was a better screening method for SGA prediction compared with using EFW. Several reasons could explain the lower sensitivity of EFW, including increased variability due to multiple measurements, or the fact that AC growth is affected more than is cephalic or long-bone growth in SGA fetuses.
As expected, a shorter ultrasound-delivery interval was associated with better prediction of SGA. Depending on the objective of screening, the optimal timing of third-trimester ultrasound may vary. If the goal is to screen for severe early-onset SGA, then the 28-32-week range would be logical. On the other hand, if the objective is to predict birth weight or to screen for late-onset SGA, the optimal window for screening might be around 35-37 weeks, as suggested by Fadigas et al. 20 . In a recent randomized controlled trial, Roma et al. 19 compared the utility of routine third-trimester ultrasound examination at 36 vs 32 weeks for detecting fetal growth restriction. Despite similar FPRs, DRs were superior at 36 weeks.
In another large screening study in more than 30 000 singleton pregnancies at 30-34 weeks, Bakalis et al. 18 found that combined screening by maternal characteristics and obstetric history predicted 79% of the SGA neonates that delivered < 5 weeks following assessment, at a 10% FPR; the DR for the prediction of SGA neonates delivering ≥ 5 weeks from the time of assessment was 53%.
In another recent study, Triunfo et al. 26 compared, in an unselected population, routine third-trimester ultrasound with a contingent approach according to risk accrued in the second trimester. They concluded that a policy of third-trimester ultrasound in 50% of the population based on combined first-and second-trimester risks achieves a diagnostic performance for late fetal growth restriction that is equivalent to that resulting from third-trimester ultrasound performed routinely in all pregnant women. Further studies should examine the timing of third-trimester ultrasound (early vs late) based on risk assessment in the second trimester.
We found the Gardosi customized curves to have a relatively poor predictive value, in contrast with most previous reports 7, 8, 27 . Several factors could explain this finding. First, the coefficients used in this study were taken from the United States population, in the absence of specific Canadian data 7, 8 . Differences between Canadian and American populations, therefore, particularly in weight and BMI, could partly explain this discrepancy. The ethnic distribution between the two countries is also different, with the proportion of 'non-white' women being higher in the United States. In a recent large study, Sovio et al. 14 found that customization of the EFW did not increase the strength of association between SGA and neonatal morbidity. Likewise, the INTERGROWTH-21 st Project results suggest that ethnic variability does not influence fetal growth, at least in healthy uncomplicated pregnancies 6 . The Hadlock formula for EFW was derived from a relatively small number of fetuses: 109 in 1985 28 and 392 in 1991 10 , and its validity could therefore be criticized. However, we found the Hadlock formula to perform relatively well in the prediction of SGA.
We found a relatively poor performance of fetal growth velocity (i.e. FGVAC) for predicting SGA. Recently, several studies have reported on the potential of fetal growth velocity assessment. Deter et al. 29 analyzed various complex models of growth trajectories in pregnancies without SGA, and concluded that combining fetal biometry and growth velocity could be used to determine individualized third-trimester size standards. However, this study was not designed for testing SGA prediction. Sovio et al. 14 analyzed growth velocity as Table 4 Comparison of receiver-operating characteristics (ROC) curves for different screening methods for predicting small-for-gestationalage neonate by method of DeLong et al. 25 
Screening method
Hadlock AC 11 Salomon AC 9 Intergrowth AC 6 Hadlock EFW 10 Gardosi EFW the difference in AC Z-score, comparing the last scan before birth with the scan at 20 weeks, in almost 4000 women. They found that an EFW < 10 th percentile was only associated with the risk of neonatal morbidity if the AC growth velocity was in the lowest decile. However, this study did not compare directly the performance of SGA prediction by AC alone vs AC growth velocity. Our study has strengths and weaknesses. It is the first to compare recent fetal growth curves, including those of Gardosi et al. 7, 8 and Salomon et al. 9 , the INTERGROWTH-21 st Project 6 and fetal growth velocity in the third trimester, to historical ones such as the Hadlock curves 10, 28 . Our objective was to be as representative as possible of routine screening in clinical practice. Therefore, we did not exclude women with pregnancy complications such as pre-eclampsia, gestational diabetes or preterm labor. Although women were recruited in a prospective cohort in the first trimester, with numerous additional tests and surveys, the ultrasound measurements were performed in a routine clinical setting. The inclusion of multiple operators reflects real life and captures the variability that is present in multicenter data. While gestational age at ultrasound ranged from 28 to 41 weeks of gestation, the majority of scans were performed around 32 weeks. Another limitation of this prospective cohort is that only 77% of women had a third-trimester ultrasound examination, although this was encouraged (but not funded) as part of the study. This could have introduced a selection bias. However, in our cohort, the proportion of SGA in pregnancies with and those without ultrasound screening was the same (8.1% vs 8.8%, P = 0.7).
In conclusion, routine third-trimester ultrasound screening provides poor to moderate prediction for SGA. A single measurement of AC performs slightly better than does EFW. A shorter interval between the last ultrasound examination and delivery improves prediction. Further studies are needed to test the addition of maternal or biological characteristics for SGA screening. 
